Open AccessFOS-like antigen 1 is a prognostic biomarker in hepatocellular carcinoma
Author(s) -
Li Li,
Wenqi Zhang,
Song Zhao,
Ming Sun
Publication year - 2019
Publication title -
the saudi journal of gastroenterology/saudi journal of gastroenterology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.608
H-Index - 32
eISSN - 1998-4049
pISSN - 1319-3767
DOI - 10.4103/sjg.sjg_595_18
Subject(s) - medicine , hepatocellular carcinoma , stage (stratigraphy) , biomarker , cancer , hazard ratio , metastasis , cancer research , oncology , confidence interval , biology , paleontology , biochemistry
The prognosis of hepatocellular carcinoma (HCC) is very dismal and the targeted drugs of HCC are limited. Studies of HCC prognostic biomarkers have made little progress, though many new techniques such as high-throughput sequencing have been applied. FOS-like antigen 1 (FOSL1) is generally accepted as a proto-oncogene but its clinical significance in HCC has never been elucidated.